2 results
Approved WMOCompleted
To test whether treatment with oral imatinib reduce disease burden and consumption of medical resources.
Approved WMORecruiting
The aim of this study is to investigate the immune response to a primary and a booster immunization with a tetravalent MenACWY-TT conjugate vaccine in older persons aged 65-85 years of age.